Cite
HARVARD Citation
Lightman, S. et al. (2015). Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. Annals of the rheumatic diseases. 74 (6), pp. 1138-1144. [Online].